[胃得乐制剂治疗消化性溃疡的临床试验]

[Clinical trial of the preparation Caved S in treating peptic ulcer].

作者信息

Brailski K H, Kadiian K H, Bozhiianov V

出版信息

Vutr Boles. 1975;14(4):101-6.

Abstract

The observations upon the therapeutic effect of Caved S preparation are reported, being a combination of deglycyrrhizinated liquorice, alkalizing substances and vagolytic drugs. The clinical trial of the medicine reveals it to be with a quick effect on the subjective complaints good tolerance and no manifested disturbances on water and electrolyte balance. It is suitable for the treatment of patients with gastric and duodenal ulcers. Ulcer niche roentgenologically is healed in 37,5% of the patients with gastric ulcer and in 33% in the patients with duodenal ulcer. Endoscopically, the niche is healed in 25% of the patients with gastric ulcer and in 28,5%--with duodenal ulcer. The medicine is with no effect in cases of gastric callous ulcer, as well as with pyloric stenosis.

摘要

报告了对Caved S制剂治疗效果的观察结果，该制剂是去甘草酸甘草、碱化物质和解迷走神经药物的组合。该药物的临床试验表明，它对主观症状起效快，耐受性良好，对水和电解质平衡无明显干扰。它适用于治疗胃溃疡和十二指肠溃疡患者。在胃溃疡患者中，37.5%的患者溃疡龛在X线检查中愈合，十二指肠溃疡患者中这一比例为33%。在内镜检查中，胃溃疡患者中有25%的溃疡龛愈合，十二指肠溃疡患者中有28.5%愈合。该药物对胃胼胝性溃疡以及幽门狭窄病例无效。